Augustine Lawlor, Director at Gyre Therapeutics, holds 681.41K shares in Leap Therapeutics (Ticker: LPTX), holds 0.00 shares in Gyre Therapeutics (Ticker: GYRE), holds 0.00 shares in Cardiovascular Systems (Ticker: CSII).
Augustine Lawlor latest transaction was an Uninformative Buy of $12.20K.
What was Augustine Lawlor's most profitable transaction?
Augustine Lawlor’s most profitable transaction was an Informative Sell of GBIM stock on February 24, 2016. The return on the trade was 84.80%.
What is Augustine Lawlor's role in Gyre Therapeutics?
Augustine Lawlor's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.